Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype.
Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype.
复制标题
DOI:
10.1371/journal.pone.0108263
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Obermayer-Pietsch B
中科院分区:
文献类型:
--
作者:
Lerchbaum E;Schwetz V;Rabe T;Giuliani A;Obermayer-Pietsch B
To evaluate the association between androstenedione, testosterone, and free testosterone and metabolic disturbances in polycystic ovary syndrome. We analyzed the association between androstenedione, testosterone, and free testosterone and metabolic parameters in a cross-sectional study including 706 polycystic ovary syndrome and 140 BMI-matched healthy women. Polycystic ovary syndrome women were categorized into 4 groups: normal androstenedione and normal free testosterone (NA/NFT), elevated androstenedione and normal free testosterone (HA/NFT), normal androstenedione and elevated free testosterone (NA/HFT), elevated androstenedione and free testosterone (HA/HFT). Polycystic ovary syndrome women with elevated free testosterone levels (HA/HFT and NA/HFT) have an adverse metabolic profile including 2 h glucose, HbA1c, fasting and 2 h insulin, area under the insulin response curve, insulin resistance, insulin sensitivity index (Matsuda), triglycerides, total and high density lipoprotein cholesterol levels compared to NA/NFT (p<0.05 for all age- and BMI-adjusted analyses). In binary logistic regression analysis adjusted for age and BMI, odds ratio for insulin resistance was 2.78 (1.34–5.75, p = 0.006) for polycystic ovary syndrome women with HA/HFT compared to NA/NFT. We found no significantly increased risk of metabolic disorders in polycystic ovary syndrome women with HA/NFT. In multiple linear regression analyses (age- and BMI-adjusted), we found a significant negative association between androstenedione/free testosterone-ratio and area under the insulin response curve, insulin resistance, and total cholesterol/high density lipoprotein cholesterol-ratio and a positive association with Matsuda-index, and high density lipoprotein cholesterol (p<0.05 for all). Polycystic ovary syndrome women with elevated free testosterone levels but not with isolated androstenedione elevation have an adverse metabolic phenotype. Further, a higher androstenedione/free testosterone-ratio was independently associated with a beneficial metabolic profile.
登录
查看更多内容
影响因子:
9.8
作者:
Bernasconi, D;DelMonte, P;Marugo, M
通讯作者:
Marugo, M
影响因子:
5.4
作者:
Essah, P. A.;Nestler, J. E.;Carmina, E.
通讯作者:
Carmina, E.
影响因子:
6.1
作者:
Fauser, BCJM;Chang, J;Lobo, R
通讯作者:
Lobo, R
影响因子:
9.8
作者:
Ivandic, A;Prpic-Krizevac, I;Juric, M
通讯作者:
Juric, M
影响因子:
3.2
作者:
Lerchbaum, Elisabeth;Giuliani, Albrecht;Obermayer-Pietsch, Barbara
通讯作者:
Obermayer-Pietsch, Barbara